Similar articles

• Streptococcus viridans endocarditis: favorable prognosis in geriatric patients. Prognosis depends on correct identification of the organism and appropriate antibiotic therapy.

  Tan JS, Watanakunakorn C, Terhune CA Jr. Tan JS, et al. Geriatrics. 1973 Jul;28(7):68-73. Geriatrics. 1973. PMID: 4710893 No abstract available.
• [On expedient treatment of bacterial endocarditis].

  Tauchnitz C. Tauchnitz C. Z Gesamte Inn Med. 1967 May 1;22(9):263-7. Z Gesamte Inn Med. 1967. PMID: 5592682 German. No abstract available.
• Subacute bacterial endocarditis due to Streptococcus viridans in an edentulous man.

  MASSARO D, KATZ S. MASSARO D, et al. N Engl J Med. 1960 Nov 3;263:911. doi: 10.1056/NEJM196011032631810. N Engl J Med. 1960. PMID: 13767877 No abstract available.
• The present status of streptomycin in antimicrobial therapy.

  Martin WJ. Martin WJ. Med Clin North Am. 1970 Sep;54(5):1161-72. Med Clin North Am. 1970. PMID: 4097149 Review. No abstract available.
• Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin: historic overview and future considerations.

  Verhagen DW, Vedder AC, Speelman P, van der Meer JT. Verhagen DW, et al. J Antimicrob Chemother. 2006 May;57(5):819-24. doi: 10.1093/jac/dkl087. Epub 2006 Mar 20. J Antimicrob Chemother. 2006. PMID: 16549513 Review.